Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 5, 2014, Pages 3037-3042

  Schulze, Ute ^a   Hampel, Ulrike ^b   Sel, Saadettin ^a,b   Contreras Ruiz, Laura ^c   Schicht, Martin ^b   Dieckow, Julia ^a   Diebold, Yolanda ^c   Paulsen, Friedrich ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Dry eye syndrome; ITF; Ocular surface; TFF3

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOCHALASIN B; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; MITOMYCIN D; TREFOIL FACTOR FAMILY PEPTIDE 3; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRDU ASSAY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA INJURY; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LACRIMAL FLUID; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WOUND HEALING;

DRY EYE SYNDROME; ITF; OCULAR SURFACE; TFF3;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DRY EYE SYNDROMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; HUMANS; PEPTIDES; POLYMERASE CHAIN REACTION; TEARS; UP-REGULATION; WOUND HEALING;

EID: 84899998265     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13423     Document Type: Article

References (38)

1. Tiffany JM. The normal tear film. Dev Ophthalmol. 2008;41:1-20.
2. Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta. 2006;369:17-28.
3. Dry Eye Workshop Study (DEWS) Group. Research in dry eye: report of the research subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5:1-194.
4. Hoffmann W. Trefoil family (TFF) peptides and chemokine receptors: a promising relationship. J Med Chem. 2009;52: 6505-6510.
5. Langer G, Jagla W, Behrens-Baumann W, Walter S, Hoffmann W. Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells. Invest Ophthalmol Vis Sci. 1999;40: 2220-2224.
6. Steven P, Schäfer G, Nölle B, Hinz M, Hoffmann W, Paulsen F. Distribution of TFF peptides in corneal disease and pterygium. Peptides. 2004;25:819-825.
7. Dubeykovskaya Z, Dubeykovskiy A, Solal-Cohen J, Wang TC. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J Biol Chem. 2009;284:3650-3662.
8. Orime K, Shirakawa J, Togashi Y, et al. Trefoil factor 2 promotes cell proliferation in pancreatic b-cells through CXCR-4-mediated ERK1/2 phosphorylation. Endocrinology. 2013;154:54-64.
9. Xue L, Aihara E, Wang TC, Montrose MH. Trefoil factor 2 requires Na/H exchanger 2 activity to enhance mouse gastric epithelial repair. J Biol Chem. 2011;286:38375-38382.
10. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest. 2002; 32:519-527.
11. Paulsen FP, Schaudig U, Fabian A, Ehrich D, Sel S. TFF peptides and mucins are major components of dacryoliths. Graefes Arch Clin Exp Ophthalmol. 2006;244:1160-1170.
12. Posa A, Bräuer L, Schicht M, Garreis F, Beileke S, Paulsen F. Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid. Ann Anat. 2013;195:137-142.
13. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
14. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea. 2007;26:452-460.
15. Schulze U, Hampel U, Sel S, et al. Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing. Histochem Cell Biol. 2012;138:243-250.
16. Wiede A, Jagla W, Welte T, Köhnlein T, Busk H, Hoffmann W. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am J Respir Crit Care Med. 1999; 159:1330-1335.
17. Storesund T, Hayashi K, Kolltveit KM, Bryne M, Schenck K. Salivary trefoil factor 3 enhances migration of oral keratino-cytes. Eur J Oral Sci. 2008;116:135-140.
18. Rösler S, Haase T, Claassen H, et al. Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes. Arthritis Rheum. 2010;62:815-825.
19. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell, PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023-1027.
20. Li S, Sack R, Vijmasi T, et al. Antibody protein array analysis of the tear film cytokines. Optom Vis Sci. 2008;85:653-660.
21. Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198-205, e1.
22. Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52:7725-7730.
23. Enŕiquez de Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
24. Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012; 53:5443-5450.
25. Dossinger V, Kayademir T, Blin N, Gött P. Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors. Cell Physiol Biochem. 2002;12:197-206.
26. Loncar MB, Al-azzeh ED, Sommer PS, et al. Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide. Gut. 2003;52:1297-1303.
27. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11:246-258.
28. Poulsom R, Begos DE, Modlin IM. Molecular aspects of restitution: functions of trefoil peptides. Yale J Biol Med. 1996;69:137-146.
29. Kinoshita T, Taupin DR, Itoh H, Podolsky DK. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol. 2000;20:4680-4690.
30. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci. 2005;62:2932-2938.
31. Göke MN, Cool JR, Kunert KS, Fini ME, Gipson IK, Podolsky DK. Trefoil peptides promote restitution of wounded corneal epithelial cells. Exp Cell Res. 2001;264:337-344.
32. Paulsen FP, Woon CW, Varoga D, et al. Intestinal trefoil factor/ TFF3 promotes re-epithelialization of corneal wounds. J Biol Chem. 2008;283:13418-13427.
33. Oertel M, Graness A, Thim L, Bühling F, Kalbacher H, Hoffmann W. Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol. 2001;25: 418-424.
34. Chwieralski CE, Schnurra I, Thim L, Hoffmann W. Epidermal growth factor and trefoil factor family 2 synergistically trigger chemotaxis on BEAS-2B cells via different signaling cascades. Am J Respir Cell Mol Biol. 2004;31:528-537.
35. Chinery R, Playford RJ. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci (Lond). 1995;88: 401-403.
36. Dürer U, Hartig R, Bang S, Thim L, Hoffmann W. TFF3 and EGF induce different migration patterns of intestinal epithelial cells in vitro and trigger increased internalization of E-cadherin. Cell Physiol Biochem. 2007;20:329-346.
37. Schulze U, Sel S, Paulsen FP. Trefoil factor family peptide 3 at the ocular surface. A promising therapeutic candidate for patients with dry eye syndrome? Dev Ophthalmol. 2010;45:1-11.
38. Peterson DE, Barker NP, Akhmadullina LI, et al. Phase II, randomized, double-blind, placebo-controlled study of recom-binant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. J Clin Oncol. 2009;27:4333-4338.